• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BB-K8与卡那霉素在犬类和人类中的比较药代动力学。

Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans.

作者信息

Cabana B E, Taggart J G

出版信息

Antimicrob Agents Chemother. 1973 Apr;3(4):478-83. doi: 10.1128/AAC.3.4.478.

DOI:10.1128/AAC.3.4.478
PMID:4790604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC444438/
Abstract

Comparative studies in beagle dogs suggested that the pharmacokinetic profiles of BB-K8 and kanamycin are similar. After intravenous (iv) administration to dogs, BB-K8 and kanamycin were rapidly distributed in plasma and tissue fluids; their "apparent" volumes of distribution comprised approximately 23% of the total body volume. Like kanamycin, BB-K8 had a plasma half-life of about 0.8 h which paralleled the urinary excretion rate. Approximately 92% of the dose was excreted as unchanged drug within 6 h of dosing, and clearance appeared to be primarily by glomerular filtration. After intramuscular (im) administration to dogs, BB-K8 and kanamycin were totally and rapidly absorbed; peak concentrations in the plasma occurred 0.5 to 1.0 h after dosing. The kinetic parameters governing the distribution and elimination of BB-K8 and kanamycin after an im dose were similar to those obtained for iv dosing and indicate desirable dose-independent kinetics. A human pharmacokinetic study indicated that the kinetic profiles of BB-K8 and kanamycin are similar in man after im dosing. Like kanamycin, BB-K8 is rapidly absorbed, yielding peak serum concentrations of about 20 mug/ml at 1 h after a 500-mg im dose. The plasma half-life of these two drugs was approximately 2.3 h. Clearance in man was primarily by glomerular filtration, and the urinary excretion of BB-K8 and kanamycin accounted for 83% of the dose.

摘要

对比格犬的比较研究表明,BB-K8和卡那霉素的药代动力学特征相似。给犬静脉注射后,BB-K8和卡那霉素迅速分布于血浆和组织液中;它们的“表观”分布容积约占总体积的23%。与卡那霉素一样,BB-K8的血浆半衰期约为0.8小时,这与尿排泄率平行。给药后6小时内,约92%的剂量以原形药物排出,清除似乎主要通过肾小球滤过。给犬肌肉注射后,BB-K8和卡那霉素完全且迅速吸收;给药后0.5至1.0小时血浆中出现峰值浓度。肌肉注射剂量后,控制BB-K8和卡那霉素分布和消除的动力学参数与静脉注射给药时获得的参数相似,表明具有理想的非剂量依赖性动力学。一项人体药代动力学研究表明,肌肉注射给药后,BB-K8和卡那霉素在人体中的动力学特征相似。与卡那霉素一样,BB-K8迅速吸收,500毫克肌肉注射剂量后1小时血清峰值浓度约为20微克/毫升。这两种药物的血浆半衰期约为2.3小时。人体清除主要通过肾小球滤过,BB-K8和卡那霉素的尿排泄占剂量的83%。

相似文献

1
Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans.BB-K8与卡那霉素在犬类和人类中的比较药代动力学。
Antimicrob Agents Chemother. 1973 Apr;3(4):478-83. doi: 10.1128/AAC.3.4.478.
2
The pharmacokinetics of some aminoglycoside antibiotics in the horse.某些氨基糖苷类抗生素在马体内的药代动力学。
J Vet Pharmacol Ther. 1981 Dec;4(4):277-84. doi: 10.1111/j.1365-2885.1981.tb00863.x.
3
Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.三种氨基糖苷类抗生素BB-K8、卡那霉素和庆大霉素的体外活性比较
Antimicrob Agents Chemother. 1973 Aug;4(2):133-9. doi: 10.1128/AAC.4.2.133.
4
Pharmacokinetics of vertilmicin, a novel aminoglycoside antibiotic, in rats and dogs.
Eur J Drug Metab Pharmacokinet. 2010 Sep;35(1-2):47-53. doi: 10.1007/s13318-010-0007-8.
5
Pharmacokinetics of Sch 34343 in rats and dogs.Sch 34343在大鼠和犬体内的药代动力学
J Antimicrob Chemother. 1985 Jun;15 Suppl C:219-26. doi: 10.1093/jac/15.suppl_c.219.
6
Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function.氨基糖苷类药物在肾功能正常和受损受试者中的药代动力学。
Antibiot Chemother (1971). 1978;25:163-80. doi: 10.1159/000401061.
7
Clinical pharmacokinetics of amikacin in dogs.
Am J Vet Res. 1985 Aug;46(8):1793-6.
8
[Pharmacokinetics of arbekacin in dogs. I. Serum concentration and urinary excretion].阿贝卡星在犬体内的药代动力学。I. 血清浓度与尿排泄
Jpn J Antibiot. 1987 Feb;40(2):365-75.
9
Single-dose pharmacokinetics of 3-O-demethylfortimicin A in humans after intravenous and intramuscular administration.静脉注射和肌肉注射后3-O-去甲基福提霉素A在人体内的单剂量药代动力学。
Antimicrob Agents Chemother. 1986 Mar;29(3):400-4. doi: 10.1128/AAC.29.3.400.
10
In vitro studies of BB-K8, a new aminoglycoside antibiotic.新型氨基糖苷类抗生素BB-K8的体外研究
Antimicrob Agents Chemother. 1973 Aug;4(2):186-92. doi: 10.1128/AAC.4.2.186.

引用本文的文献

1
Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.人体和临床前动物模型中未变化药物的尿排泄检查:提高人类代谢不良的预测性。
Pharm Res. 2021 Jul;38(7):1139-1156. doi: 10.1007/s11095-021-03076-y. Epub 2021 Jul 12.
2
Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.随机对照试验中,与β-内酰胺类联合氨基糖苷类相比,双联β-内酰胺类组合疗法治疗革兰氏阴性菌具有相当的疗效和更好的安全性。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00425-19. Print 2019 Jul.
3
Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake.22种抗结核药物对有机阴离子转运多肽(OATP)介导摄取的抑制相互作用潜力的表征
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3096-105. doi: 10.1128/AAC.02765-15. Print 2016 May.
4
Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis.作为抗生素效力衡量指标的突变预防浓度:对结核分枝杆菌临床分离株的研究
Antimicrob Agents Chemother. 2000 Sep;44(9):2581-4. doi: 10.1128/AAC.44.9.2581-2584.2000.
5
Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.恒河猴单次或重复静脉注射后,低清除率单层脂质体中阿米卡星的药代动力学和尿排泄情况。
Antimicrob Agents Chemother. 1999 Mar;43(3):503-9. doi: 10.1128/AAC.43.3.503.
6
Pharmacokinetic study of sisomicin in humans.西索米星在人体中的药代动力学研究。
J Pharmacokinet Biopharm. 1981 Oct;9(5):535-51. doi: 10.1007/BF01061025.
7
Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers.对人类志愿者静脉注射和肌肉注射新氨基糖苷类药物地贝卡星后的药代动力学研究。
Antimicrob Agents Chemother. 1980 Sep;18(3):372-6. doi: 10.1128/AAC.18.3.372.
8
Clinical pharmacokinetics of the antituberculosis drugs.抗结核药物的临床药代动力学。
Clin Pharmacokinet. 1984 Nov-Dec;9(6):511-44. doi: 10.2165/00003088-198409060-00003.
9
Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.五种氨基糖苷类抗生素对革兰氏阴性杆菌和金黄色葡萄球菌的体外活性。
Antimicrob Agents Chemother. 1973 Dec;4(6):617-25. doi: 10.1128/AAC.4.6.617.
10
Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections.阿米卡星(BB-K8)治疗多重耐药变形杆菌感染。
Antimicrob Agents Chemother. 1974 May;5(5):435-8. doi: 10.1128/AAC.5.5.435.

本文引用的文献

1
Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.快速静脉注射后化合物的分布容积和半衰期的估算。
J Pharm Sci. 1967 Apr;56(4):529-31. doi: 10.1002/jps.2600560424.
2
The relationship between kanamycin pharmacokinetics: distribution and renal function.
Clin Pharmacol Ther. 1969 Jul-Aug;10(4):543-50. doi: 10.1002/cpt1969104543.
3
New method for calculating the intrinsic absorption rate of drugs.计算药物内在吸收速率的新方法。
J Pharm Sci. 1968 Jun;57(6):918-28. doi: 10.1002/jps.2600570602.
4
Concept of a volume of distribution and possible errors in evaluation of this parameter.分布容积的概念以及该参数评估中可能存在的误差。
J Pharm Sci. 1968 Jan;57(1):128-33. doi: 10.1002/jps.2600570125.
5
Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.将人体视为具有单室性质进行药代动力学分析时存在的缺点。
J Pharm Sci. 1968 Jan;57(1):117-23. doi: 10.1002/jps.2600570123.
6
Pharmacokinetic evaluation of the oral absorption of different ampicillin preparations in beagle dogs.比格犬口服不同氨苄西林制剂吸收的药代动力学评价
Antimicrob Agents Chemother (Bethesda). 1969;9:35-41.
7
Absorption, distribution, and elimination of spectinomycin dihydrochloride in man.
Int Z Klin Pharmakol Ther Toxikol. 1968 Apr;1(4):261-85.